OverviewSuggest Edit

Check-Cap is a medical diagnostics company. It develops C-Scan, a capsule-based system for colorectal cancer screening. The company utilizes X-ray and wireless communication technologies for the capsule to generate information on the contours of the inside of the colon and create its 3D map. The system allows physicians to look for polyps and other abnormalities.
TypePublic
Founded2005
HQIsfiya, IL
Websitecheck-cap.com

Latest Updates

Employees (est.) (Jul 2021)65
Share Price (Oct 2021)$0.8
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Check-Cap

Steven Hanley

Steven Hanley

Chairman
Alex Ovadia

Alex Ovadia

Chief Executive Officer
Yoav Kimchy

Yoav Kimchy

Founder and Chief Technology Officer
Boaz Shpigelman

Boaz Shpigelman

Vice President of Research & Development
Mira Rosenzweig

Mira Rosenzweig

Chief Financial Officer
Noa Reshef

Noa Reshef

Director of Human Resources
Show more

Check-Cap Office Locations

Check-Cap has an office in Isfiya
Isfiya, IL (HQ)
Abba Hushi Boulevard 29
Show all (1)

Check-Cap Financials and Metrics

Check-Cap Revenue

Market capitalization (18-Oct-2021)

59.2m

Closing stock price (18-Oct-2021)

0.8
Check-Cap's current market capitalization is $59.2 m.
Show all financial metrics

Check-Cap Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Check-Cap Online and Social Media Presence

Embed Graph

Check-Cap News and Updates

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

ISFIYA, Israel, Oct. 18, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect...

Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results

ISFIYA, Israel, March 19, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free, screening test to detect...

Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds

ISFIYA, Israel, July 23, 2020 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan®, the first and only patient-friendly preparation-free screening test to detect...

Check-Cap Frequently Asked Questions

  • When was Check-Cap founded?

    Check-Cap was founded in 2005.

  • Who are Check-Cap key executives?

    Check-Cap's key executives are Steven Hanley, Alex Ovadia and Yoav Kimchy.

  • How many employees does Check-Cap have?

    Check-Cap has 65 employees.

  • Who are Check-Cap competitors?

    Competitors of Check-Cap include Agena Bioscience, EDP Biotech and Preora Healthcare.

  • Where is Check-Cap headquarters?

    Check-Cap headquarters is located at Abba Hushi Boulevard 29, Isfiya.

  • Where are Check-Cap offices?

    Check-Cap has an office in Isfiya.

  • How many offices does Check-Cap have?

    Check-Cap has 1 office.